RTTNews | Jan 4, 2021 07:40AM EST

07:40 Monday, January 4, 2021 (RTTNews.com) - Enzo Biochem, Inc. (ENZ) has received an expansion of its Emergency Use Authorization from the FDA authorizing the use of pooled samples containing up to five individual swab specimens with the AMPIPROBE SARS-Cov-2 Test System utilizing tests on three different platforms including Enzo's GENFLEX automated high-throughput platform.

"This expansion of the EUA to include pooled samples can rapidly expand testing capacity based on ENZO's proven, reliable and sensitive PCR-based molecular test for SARS-Cov-2," said Elazar Rabbani, Enzo CEO.

Shares of Enzo Biochem were up 11% in pre-market trade on Monday.

Read the original article on RTTNews ( https://www.rttnews.com/3157313/enzo-biochem-reports-expansion-of-eua-to-include-pooled-samples-with-sars-cov-2-test-system.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved